Relaxed specificity of matrix metalloproteinases (MMPS) and TIMP insensitivity of tumor necrosis factor-alpha (TNF-alpha) production suggest the major TNF-alpha converting enzyme is not an MMP

Biochem Biophys Res Commun. 1996 Aug 14;225(2):400-5. doi: 10.1006/bbrc.1996.1186.

Abstract

Tumor necrosis factor-alpha is released from cells by a proteolytic cleavage. Previous work suggested that a specific, non-matrix metalloproteinase carries out this cleavage, but matrix metalloproteinases have also been implicated. In this paper, we report that none of the matrix metalloproteinases tested cleaved peptide substrates as specifically as the non-matrix metalloproteinase. A matrix metalloproteinase did process tumor necrosis factor-alpha extracted from COS cells, but neither tissue inhibitor of metalloproteinases-1 nor -2 blocked tumor necrosis factor-alpha processing by human monocytes. Moreover, tissue inhibitor of metalloproteinases-1 had at most a partial effect on the in vivo release of the cytokine in mice. We conclude that a non-matrix metalloproteinase is the major physiological tumor necrosis factor-alpha convertase.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • ADAM Proteins
  • ADAM17 Protein
  • Animals
  • CHO Cells
  • Cell Line
  • Cells, Cultured
  • Cricetinae
  • Glycoproteins / pharmacology*
  • Humans
  • Metalloendopeptidases / metabolism*
  • Mice
  • Mice, Inbred BALB C
  • Protein Processing, Post-Translational
  • Recombinant Proteins / pharmacology
  • Substrate Specificity
  • Tissue Inhibitor of Metalloproteinases
  • Tumor Cells, Cultured
  • Tumor Necrosis Factor-alpha / biosynthesis*
  • Tumor Necrosis Factor-alpha / metabolism

Substances

  • Glycoproteins
  • Recombinant Proteins
  • Tissue Inhibitor of Metalloproteinases
  • Tumor Necrosis Factor-alpha
  • ADAM Proteins
  • Metalloendopeptidases
  • ADAM17 Protein